1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multiregional genetic evolution of metastatic uveal melanoma
    Journal Article

    Rodriguez, D. A.; Yang, J.; Durante, M. A.; Shoushtari, A. N.; Moschos, S. J.; Wrzeszczynski, K. O.; Harbour, J. W.; Carvajal, R. D.
    npj Genomic Medicine (2021)

    Fulltext@MSK | Save
  • Machine learning and artificial intelligence in neurosurgery: Status, prospects, and challenges
    Editorial

    Dagi, T. F.; Barker, F. G. 2nd; Glass, J.
    Neurosurgery (2021)

    Fulltext@MSK | Save
  • Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
    Journal Article

    Mao, N.; Zhang, Z.; Lee, Y. S.; Choi, D.; Agudelo Rivera, A.; Li, D.; Lee, C.; Haywood, S.; Chen, X.; Chang, Q.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): A phase 1b/2 open-label study
    Journal Article

    Berdeja, J. G.; Madduri, D.; Usmani, S. Z.; Jakubowiak, A.; Agha, M.; Cohen, A. D.; Stewart, A. K.; Hari, P.; Htut, M.; Lesokhin, A.; more...
    Lancet (2021)

    Fulltext@MSK | Save
  • Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
    Journal Article

    Stahl, M.; Narendra, V.; Jee, J.; Derkach, A.; Maloy, M.; Geyer, M. B.; Mato, A. R.; Roeker, L. E.; Tallman, M. S.; Shah, G. L.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' reply
    Correspondence

    Pires da Silva, I.; Ahmed, T.; Reijers, I. L. M.; Warner, A. B.; Randall Patrinely, J.; Serra-Bellver, P.; Allayous, C.; Mangana, J.; Zimmer, L.; Trojaniello, C.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Recommendations for testing and treating outpatient cancer patients in the era of COVID-19
    Guidelines

    Reidy-Lagunes, D.; Saltz, L.; Postow, M.; Scordo, M.; Moskowitz, A.; Tew, W.; Zamarin, D.; Redelman-Sidi, G.
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S. V.; Drill, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells
    Journal Article

    Veatch, J. R.; Singhi, N.; Srivastava, S.; Szeto, J. L.; Jesernig, B.; Stull, S. M.; Fitzgibbon, M.; Sarvothama, M.; Yechan-Gunja, S.; James, S. E.; more...
    Journal of Clinical Investigation (2021)

    Fulltext@MSK | Save
  • First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas
    Journal Article

    Piha-Paul, S. A.; Geva, R.; Tan, T. J.; Lim, D. W. T.; Hierro, C.; Doi, T.; Rahma, O.; Lesokhin, A.; Luke, J. J.; Otero, J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save